In this week's DermwireTV, the FDA approves the first new therapy for spontaneous urticaria in more than 10 years; a new study examines investigational oral Icotrokinra in adolescents with plaque psoriasis; and Practical Dermatology launches a new series addressing trends and innovations in the treatment of skin cancer.
advertisement
Dupixent Approved for Spontaneous Urticaria
Share
SaveShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Recommended
Details
Overview
In this week's DermwireTV, the FDA approves the first new therapy for spontaneous urticaria in more than 10 years; a new study examines investigational oral Icotrokinra in adolescents with plaque psoriasis; and Practical Dermatology launches a new series addressing trends and innovations in the treatment of skin cancer.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?